The FDA has approved Thermo Fisher’s Oncomine Dx Target Test, a next-generation sequencing based companion diagnostic, to ...

Researchers at Weill Cornell Medicine have made a breakthrough in the fight against liver cancer, by identifying a biomarker ...

The use of engineered viruses in cancer treatment is gaining significant traction, offering new avenues for enhancing immune ...

The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the ...

Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies for rare cancers, ...

Developed by AI, Lantern Pharma's investigational drug LP-184 has received FDA Fast-Track Designation for glioblastoma.

The Merlin test (CP-GEP), a molecular diagnostic tool developed by SkylineDx, significantly reduces the need for sentinel ...

Bayer and MOMA Therapeutics have announced a new collaboration aimed at advancing precision cancer treatments. The ...

The FDA has approved Genentech’s Itovebi™ (inavolisib) as a targeted therapy for adults with advanced hormone ...

ADCs are at the forefront of cancer treatment, providing targeted therapies with promising results for lung cancer. We have ...

Oncolytic viruses are emerging as a promising development in cancer treatment, not only destroying cancer cells but also modulating the tumor microenvironment to enhance immune responses. We had an ...